Anika Therapeutics reported $145K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Abbott ABT:US $ 24304M 166M
Acorda Therapeutics ACOR:US $ 0.01M 0M
Agenus AGEN:US $ 2.67M 0.1M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Anika Therapeutics ANIK:US $ 0.14M 0M
Arrowhead Research ARWR:US $ 198K 1000
Chemocentryx CCXI:US $ 0.07M 0M
Clovis Oncology CLVS:US $ 0.14M 0.02M
Enanta Pharmaceuticals ENTA:US $ 0.21M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Immunogen IMGN:US $ 2.2M 0M
Insmed INSM:US $ 1.19M 6K
Integra Lifesciences IART:US $ 0.9M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Merit Medical Systems MMSI:US $ 646.37M 4.84M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.47M 0.01M
Stryker SYK:US $ 38M 0M
Surmodics SRDX:US $ 0.7M 0M
Veracyte VCYT:US $ 0.07M 0M
Xencor XNCR:US $ 0.6M 0M
Zimmer Biomet Holdings Inc ZBH:US $ 3.1M 0